株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のヒト成長ホルモン (HGH) 市場

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 336016
出版日 ページ情報 英文 78 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=116.15円で換算しております。
Back to Top
世界のヒト成長ホルモン (HGH) 市場 Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年01月18日 ページ情報: 英文 78 Pages
概要

当レポートでは、世界のヒト成長ホルモン (HGH) 市場について調査分析し、概要、市場分析、市場力学、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 ヒト成長ホルモン (HGH)

  • 成長ホルモン (GH) の生理作用
  • GH分泌制御
  • GH欠乏症 (GHD)
  • GH/HGH療法とその他の応用
  • 組み換えヒト成長ホルモン (rhGH)

第2章 HGH市場の分析

  • 世界市場
  • 地域市場
  • VRS-317 市場機会
  • TransCon-HGH 世界市場の機会

第3章 市場力学

  • 主要動向
  • 業界の発展
  • 成長促進要因
  • 課題

第4章 競合情勢

第5章 企業プロファイル

  • 事業概要、財務概要、事業戦略
    • Roche Holdings AG
    • Novo Nordisk
    • Pfizer, Inc.
    • Eli Lilly and Company

第6章 市場見通し

  • 市場予測
  • 予測手法

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Growth hormone (GH)/ Human Growth hormone (hGH) is a type of peptide hormone produced by the body which is responsible for stimulating cell reproduction, growth and regeneration amongst humans. Within the anterior of pituitary glands, lateral wings are present the somatotropic cells which synthesize, store, and secrete the GH, a 191-amino acid in single chain polypeptide. It is responsible for keeping a check over the normal human growth and development especially amongst the teenagers and children. Apart from stimulating cell growth and maintaining muscle mass, hGH also prompts the liver to produce IGF-l which in turn regulates the metabolic functioning of muscles, tissues and osteocytes.

The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD), which is a medical condition affecting both children and adults. Amongst children, GHD could be associated with congenital conditions, like marred pituitary development and other genetic abnormalities. On the other hand, GHD amongst adults is supposedly linked with pituitary tumors and it usually has non-specific symptoms, like weight gain, reduced energy levels, disturbed sleep, and emotional sickness. Depending upon the indications targeted, the hGH market can be segmented into two broad categories; Pediatric GHD and others. Others segment include adult GHD, PWS, ISS and other GH related abnormalities.

The global hGH market is driven by development and entry of long-acting drugs, rising cases of cancer and HIV/AIDS, higher incidence of GHD and other related diseases, rising healthcare expenditure and increasing purchasing power. However, this market growth is challenged by high cost of drugs, off-label uses of hGH drugs and side effects related to rhGH.

The report "Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the US, Europe and Japan. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Novartis AG., Pfizer Inc., Eli Lilly and Company and Novo Nordisk A/S are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global human growth market along with the study of the regional markets.

Table of Contents

1. Overview

  • 1.1 Human Growth Hormone
  • 1.2 Physiological Effects of hGH
  • 1.3 GH Deficiency (GHD)
  • 1.4 Recombinant Human Growth Hormone (rhGH)
  • 1.5 hGH Market by Indications

2. Global hGH Market

  • 2.1 Global hGH Market by Value
  • 2.2 Global hGH Market Forecast by Value
  • 2.3 Global hGH Market by Volume
  • 2.4 Global hGH Market Forecast by Volume
  • 2.5 Global hGH Market by Indications
    • 2.5.1 Global Pediatric GHD Market by Value
    • 2.5.2 Global Pediatric GHD Market Forecast by Value
    • 2.5.3 Global Other hGH Market by Value
    • 2.5.4 Global Other hGH Market Forecast by Value
  • 2.6 Global hGH Market by Regions

3. Regional Markets

  • 3.1 The US
    • 3.1.1 The US hGH Market by Value
    • 3.1.2 The US hGH Market Forecast by Value
    • 3.1.3 The US hGH Market by Indication
    • 3.1.4 The US Pediatric GHD Market Forecast by Value
  • 3.2 Europe
    • 3.2.1 Europe hGH Market by Value
    • 3.2.2 Europe hGH Market Forecast by Value
    • 3.2.3 Europe hGH Market by Indication
    • 3.2.4 Europe Pediatric GHD Market Forecast by Value
  • 3.3 Japan
    • 3.3.1 Japan hGH Market by Value
    • 3.3.2 Japan hGH Market Forecast by Value
    • 3.3.3 Japan hGH Market by Indication
    • 3.3.4 Japan Pediatric GHD Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Development and Entry of Long-Acting Drugs
    • 4.1.2 Rising Cases of Cancer and HIV/AIDS
    • 4.1.3 Increasing Incidence of CKD and ESRD
    • 4.1.4 Upsurge in Healthcare Expenditure
    • 4.1.5 Increasing Global GDP
    • 4.1.6 Higher Incidence of GHD and Other Related Diseases
  • 4.2 Trends & Development
    • 4.2.1 hGh Used as Performance Enhance Drug
    • 4.2.2 Innovation in Drug Delivery System
  • 4.3 Challenges
    • 4.3.1 High Cost of Treatment
    • 4.3.2 Off Label Uses of GH
    • 4.3.3 Side Effects of rhGH

5. Competitive Landscape

  • 5.1 Global hGH Market
    • 5.1.1 Global hGH Market Share by Company
    • 5.1.2 Net Sales and Market Cap Comparison
  • 5.2 The US hGH Market Share

6. Company Profiles

  • 6.1 Novartis AG
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Pfizer Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Eli Lilly and Company
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Novo Nordisk A/S
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • hGH Secretion Control
  • hGH's Physiological Effect
  • hGH Market Segmentation by Indication
  • Global hGH Market by Value (2012-2016)
  • Global hGH Market Forecast by Value (2017-2021)
  • Global hGH Market by Volume (2012-2016)
  • Global hGH Market Forecast by Volume (2017-2021)
  • Global hGH Market by Indications (2016)
  • Global Pediatric GHD Market by Value (2012-2016)
  • Global Pediatric GHD Market Forecast by Value (2017-2021)
  • Global Other hGH Market by Value (2012-2016)
  • Global Other hGH Market Forecast by Value (2017-2021)
  • Global hGH Market by Regions (2016)
  • The US hGH Market by Value (2012-2016)
  • The US hGH Market Forecast by Value (2017-2021)
  • The US hGH Market by Indication (2016)
  • The US Pediatric GHD Market Forecast by Value (2016-2021)
  • Europe hGH Market by Value (2012-2016)
  • Europe hGH Market Forecast by Value (2017-2021)
  • Europe hGH Market by Indication (2016)
  • Europe Pediatric GHD Market Forecast by Value (2016-2021)
  • Japan hGH Market by Value (2012-2016)
  • Japan hGH Market Forecast by Value (2017-2021)
  • Japan hGH Market by Indication (2016)
  • Japan Pediatric GHD Market Forecast by Value (2016-2021)
  • Global New Cancer Patients by Volume (2012-2016)
  • Global ESRD Patients Volume (2012-2016)
  • Global Healthcare Expenditure Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Market Share by Company (2016)
  • The US hGH Market Value Share by Company (2016)
  • Novartis AG Revenue by Segment (2015)
  • Novartis AG Revenue and Net Income (2011-2015)
  • Novartis AG R&D Expenditure (2013-2015)
  • Pfizer Inc. Revenue by Segment (2015)
  • Pfizer Inc. Revenue and Net Income (2011-2015)
  • Pfizer Inc. R&D Expenditure (2013-2015)
  • Eli Lilly and Company Revenue by Segment (2015)
  • Eli Lilly and Company Revenue and Net Income (2011-2015)
  • Eli Lilly and Company R&D Expenditure (2013-2015)
  • Novo Nordisk A/S Revenue by Segment (2015)
  • Novo Nordisk A/S Net Sales and Net Profit (2011-2015)
  • Novo Nordisk A/S R&D Expenditure (2013-2015)

List of Tables

  • Long acting hGH Drugs in Pipeline (2016)
  • Average Annual Cost of hGH Therapy for Children and Adults
  • Global hGH Sales & Capitalization by Company (2015)
  • New Products of Pfizer with FDA Approval (2015/2016)
  • New Products of Novo Nordisk A/S in Pipeline (2016)
Back to Top